6-(4-Aminopiperidin-1-yl)pyridine-3-carboxylic acid dihydrochloride

Catalog No.: 
ACGEKK825
CAS No.: 
1803594-10-6
Molecular Formula: 
C11H17Cl2N3O2
Molecular Weight: 
294.18
6-(4-Aminopiperidin-1-yl)pyridine-3-carboxylic acid dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$148.00InquiryInquiry
100mg95%$213.00InquiryInquiry
250mg95%$297.00InquiryInquiry
1g95%$580.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(4-Aminopiperidin-1-yl)pyridine-3-carboxylic acid dihydrochloride
IUPAC Name6-(4-aminopiperidin-1-yl)nicotinic acid dihydrochloride
MDL No.0
Molecular FormulaC11H17Cl2N3O2
Molecular Weight294.18
SMILESO=C(C1=CC=C(N2CCC(N)CC2)N=C1)O.[H]Cl.[H]Cl
InChI KeyRYIRUOMKUVYZEF-UHFFFAOYSA-N
Synonym6-(4-aminopiperidin-1-yl)pyridine-3-carboxylic acid dihydrochloride
CAS No.1803594-10-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233

Synthetic Route by SureRoute

1. ACGEKK825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVWZJ540 route compound structure diagram
    ACVWZJ5405326-23-8In Stock
  4. Then
  5. ACGEKK825 route product structure diagram
    ACGEKK8251803594-10-6
Inquiry

2. ACGEKK825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGEKK825 route product structure diagram
    ACGEKK8251803594-10-6
Inquiry

3. ACGEKK825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGEKK825 route product structure diagram
    ACGEKK8251803594-10-6
Inquiry

Comments (0)